Вестник рентгенологии и радиологии

Расширенный поиск

Некоторые закономерности развития радиоиндуцированных метахронных опухолей

Полный текст:

Об авторах

А. В. Важенин
ГБОУ ВПО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения РФ
д. м. н., профессор, заведующий кафедрой онкологии, лучевой диагностики и лучевой терапии

Н. А. Шаназаров
ГБОУ ВПО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения РФ
д. м. н., профессор кафедры онкологии

Е. Л. Шунько
ГБОУ ВПО «Тюменский государственный медицинский университет» Министерства здравоохранения РФ
к. м. н., доцент кафедры хирургических болезней с курсами эндоскопии, урологии и рентгенологии

Список литературы

1. Vazhenin A.V., Bekhtereva E.I., Bekhtereva S.A., Gyulov Kh.Ya. Essays primary multiplicity of malignant tumors. Chelyabinsk: Ieroglif; 2000 (in Russian).

2. Shun’ko E.L. Problem risk of developing primary multiple cancer following radiotherapy and chemotherapy first tumor in modern english literature (literature review). Sovremennye problemy nauki i obrazovaniya. 2014; 6. Available at: (accessed 16.04.2015) (in Russian).

3. Athar B.S., Paganetti H. Comparison of second cancer risk due to outoffield doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother. Oncol. 2011; 98: 87–92.

4. Bartkowiak D., Humble N., Suhr P., Hagg J., Mair K., Polivka B. et al. Second cancer after radiotherapy, 1981–2007. Radiother. Oncol. 2012; 105: 122–6.

5. Berrington de Gonzalez A., Curtis R.E., Kry S.F., Gilbert E., Lamart S., Berg Ch.D. et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 2011; 12: 353–60.

6. Shin D.W., Baik Y.J., Kim Y.W., Oh J.H., Chung Ki-W., Kim S.W. et al. Knowledge, attitudes, and practice on second primary cancer screening among cancer survivors: a qualitative study. Patient Educ. Counsel. 2011; 85: 74–8.

7. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother. Oncol. 2009; 91: 4–15.

8. Chaturvedi A.K., Engels E.A., Gilbert E.S. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J. Natl. Cancer Inst. 2007; 99: 1634–43.

9. Lawrence T.S., Ten Haken R.K., Giaccia A. Principles of radiation oncology. In: DeVita V.T. Jr., Lawrence T.S., Rosenberg S.A. (eds). Cancer: principles and practice of oncology. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2008.

10. Fraumeni J.F. Jr, Curtis R.E., Edwards B.K., Tucker M.A. Introduction. In: Curtis R.E., Freedman D.M., Ron E. et al. (eds). New malignancies among cancer survivors: SEER cancer registries, 1973–2000. Bethesda, MD: National Cancer Institute; 2006: 1–7.

11. Berrington de Gonzalez A., Curtis R., Gilbert E. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br. J. Cancer. 2010; 102: 220–6.

12. Lonn S., Gilbert E.S., Ron E., Smith S.A., Stovall M., Curtis R.E. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Cancer Epidemiol. Biomarkers Prev. 2010; 9: 464–74.

13. Clarke M., Collins R., Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087–106.

14. Roychoudhuri R., Evans H., Robinson D., Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Brit. J. Cancer. 2004; 91: 568–72.

15. Darby S.C., McGale P., Taylor C.W., Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6: 557–65.

16. Brown L.M., Chen B.E., Pfeiffer R.M. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res. Treat. 2007; 106: 439–51.

17. Zablotska L., Neugut A. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003; 97: 1404–11.

18. Hodgson D.C., Gilbert E.S., Dores G.M. Long-term solid cancer risk among 5-year survivors of Hodgkin’s lymphoma. J. Clin. Oncol. 2007; 25: 1489–9.

19. Koh E.J., Tran T.H., Heydarian M. A comparison of mantle versus involvedfield radiotherapy for Hodgkin’s lymphoma: reduction in normal tissue dose and second cancer risk. Radiation. Oncol. 2007; 2: 13.

20. 20. Cardis E., Kesminienne A., Ivanov V. Risk of thyroid cancer after exposure to 131I in childhood. J. Nat. Cancer Inst. 2005; 97: 724–32.

21. Scott B., Cardis E., Kesminienne A. Risk of thyroid cancer after exposure to 131I in childhood. J. Nat. Cancer. Inst. 2006; 98: 561.

22. Xu X.G., Bednarz B., Paganetti H. A review of dosimetry studies on externalbeam radiation treatment with respect to second cancer induction. Phys. Med. Biol. 2008; 53: 193–241.

23. Neglia J.P., Friedman D.L., Yasui Y. Second malignant neoplasms in fiveyear survivors of childhood cancer: childhood cancer survivor study. J. Natl. Cancer Inst. 2001; 93: 618–29.

24. Slinchak S.M. Multiple malignancies. Kiev: Zdorov’e; 1968 (in Russian).


Для цитирования:

Важенин А.В., Шаназаров Н.А., Шунько Е.Л. Некоторые закономерности развития радиоиндуцированных метахронных опухолей. Вестник рентгенологии и радиологии. 2015;(6):30-35.

For citation:

Vazhenin A.V., Shanazarov N.A., Shun’ko E.L. Some patterns of development radio-induced metachronous tumors. Journal of radiology and nuclear medicine. 2015;(6):30-35. (In Russ.)

Просмотров: 481

ISSN 0042-4676 (Print)
ISSN 2619-0478 (Online)